Logo image of LCID

LUCID GROUP INC (LCID) Stock Fundamental Analysis

USA - NASDAQ:LCID - US5494982029 - Common Stock

24.77 USD
+0.67 (+2.78%)
Last: 10/3/2025, 8:00:02 PM
24.87 USD
+0.1 (+0.4%)
Pre-Market: 10/6/2025, 6:32:23 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LCID. LCID was compared to 37 industry peers in the Automobiles industry. While LCID seems to be doing ok healthwise, there are quite some concerns on its profitability. LCID is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LCID had negative earnings in the past year.
In the past year LCID has reported a negative cash flow from operations.
In the past 5 years LCID always reported negative net income.
LCID had a negative operating cash flow in each of the past 5 years.
LCID Yearly Net Income VS EBIT VS OCF VS FCFLCID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -1B -2B -3B -4B

1.2 Ratios

Looking at the Return On Assets, with a value of -34.47%, LCID is doing worse than 62.16% of the companies in the same industry.
With a Return On Equity value of -71.55%, LCID perfoms like the industry average, outperforming 51.35% of the companies in the same industry.
Industry RankSector Rank
ROA -34.47%
ROE -71.55%
ROIC N/A
ROA(3y)-32.48%
ROA(5y)-41.59%
ROE(3y)-58.77%
ROE(5y)-71.55%
ROIC(3y)N/A
ROIC(5y)N/A
LCID Yearly ROA, ROE, ROICLCID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

LCID does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LCID Yearly Profit, Operating, Gross MarginsLCID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

5

2. Health

2.1 Basic Checks

LCID does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LCID has been increased compared to 1 year ago.
The number of shares outstanding for LCID has been increased compared to 5 years ago.
LCID has a better debt/assets ratio than last year.
LCID Yearly Shares OutstandingLCID Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
LCID Yearly Total Debt VS Total AssetsLCID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

LCID has an Altman-Z score of -1.87. This is a bad value and indicates that LCID is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.87, LCID is in line with its industry, outperforming 45.95% of the companies in the same industry.
LCID has a Debt/Equity ratio of 0.57. This is a neutral value indicating LCID is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.57, LCID is doing good in the industry, outperforming 67.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -1.87
ROIC/WACCN/A
WACC7.2%
LCID Yearly LT Debt VS Equity VS FCFLCID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 2.58 indicates that LCID has no problem at all paying its short term obligations.
The Current ratio of LCID (2.58) is better than 94.59% of its industry peers.
LCID has a Quick Ratio of 2.11. This indicates that LCID is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LCID (2.11) is better than 94.59% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.11
LCID Yearly Current Assets VS Current LiabilitesLCID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

6

3. Growth

3.1 Past

LCID shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -146.72%.
Looking at the last year, LCID shows a very strong growth in Revenue. The Revenue has grown by 39.01%.
LCID shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 181.26% yearly.
EPS 1Y (TTM)-146.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.24%
Revenue 1Y (TTM)39.01%
Revenue growth 3Y210.02%
Revenue growth 5Y181.26%
Sales Q2Q%29.34%

3.2 Future

Based on estimates for the next years, LCID will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.83% on average per year.
Based on estimates for the next years, LCID will show a very strong growth in Revenue. The Revenue will grow by 65.15% on average per year.
EPS Next Y2.14%
EPS Next 2Y15.05%
EPS Next 3Y18.49%
EPS Next 5Y11.83%
Revenue Next Year66.89%
Revenue Next 2Y79.33%
Revenue Next 3Y86.92%
Revenue Next 5Y65.15%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LCID Yearly Revenue VS EstimatesLCID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
LCID Yearly EPS VS EstimatesLCID Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -5 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LCID. In the last year negative earnings were reported.
Also next year LCID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LCID Price Earnings VS Forward Price EarningsLCID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LCID Per share dataLCID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

LCID's earnings are expected to grow with 18.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.05%
EPS Next 3Y18.49%

More info and screens

0

5. Dividend

5.1 Amount

LCID does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUCID GROUP INC

NASDAQ:LCID (10/3/2025, 8:00:02 PM)

Premarket: 24.87 +0.1 (+0.4%)

24.77

+0.67 (+2.78%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners74.51%
Inst Owner Change0%
Ins Owners0.29%
Ins Owner Change6.02%
Market Cap7.61B
Analysts52
Price Target25.03 (1.05%)
Short Float %N/A
Short Ratio0.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.41%
Min EPS beat(2)-11.38%
Max EPS beat(2)14.21%
EPS beat(4)3
Avg EPS beat(4)6.85%
Min EPS beat(4)-11.38%
Max EPS beat(4)15.08%
EPS beat(8)5
Avg EPS beat(8)2.1%
EPS beat(12)7
Avg EPS beat(12)1.61%
EPS beat(16)10
Avg EPS beat(16)4.35%
Revenue beat(2)0
Avg Revenue beat(2)-8.27%
Min Revenue beat(2)-9.12%
Max Revenue beat(2)-7.41%
Revenue beat(4)1
Avg Revenue beat(4)-2.54%
Min Revenue beat(4)-9.12%
Max Revenue beat(4)7.31%
Revenue beat(8)3
Avg Revenue beat(8)-5.09%
Revenue beat(12)3
Avg Revenue beat(12)-9.27%
Revenue beat(16)4
Avg Revenue beat(16)-15.7%
PT rev (1m)860.83%
PT rev (3m)870.78%
EPS NQ rev (1m)3.85%
EPS NQ rev (3m)-996.18%
EPS NY rev (1m)-782.31%
EPS NY rev (3m)-828.98%
Revenue NQ rev (1m)-5.67%
Revenue NQ rev (3m)-4.33%
Revenue NY rev (1m)-2.69%
Revenue NY rev (3m)-5.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.19
P/FCF N/A
P/OCF N/A
P/B 1.78
P/tB 1.78
EV/EBITDA N/A
EPS(TTM)-9.4
EYN/A
EPS(NY)-5.55
Fwd EYN/A
FCF(TTM)-9.93
FCFYN/A
OCF(TTM)-7.34
OCFYN/A
SpS3.02
BVpS13.9
TBVpS13.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.47%
ROE -71.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.48%
ROA(5y)-41.59%
ROE(3y)-58.77%
ROE(5y)-71.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 215.3%
Cap/Sales 85.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.11
Altman-Z -1.87
F-Score4
WACC7.2%
ROIC/WACCN/A
Cap/Depr(3y)421.76%
Cap/Depr(5y)1286.62%
Cap/Sales(3y)146.37%
Cap/Sales(5y)2710.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.24%
EPS Next Y2.14%
EPS Next 2Y15.05%
EPS Next 3Y18.49%
EPS Next 5Y11.83%
Revenue 1Y (TTM)39.01%
Revenue growth 3Y210.02%
Revenue growth 5Y181.26%
Sales Q2Q%29.34%
Revenue Next Year66.89%
Revenue Next 2Y79.33%
Revenue Next 3Y86.92%
Revenue Next 5Y65.15%
EBIT growth 1Y-0.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.2%
EBIT Next 3Y18.02%
EBIT Next 5Y14.56%
FCF growth 1Y18.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.09%
OCF growth 3YN/A
OCF growth 5YN/A